Literature DB >> 17932095

Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland.

S M Holloway1, D E Wilcox, A Wilcox, J C S Dean, J N Berg, D R Goudie, M A Denvir, M E M Porteous.   

Abstract

OBJECTIVES: To assess life expectancy and cardiovascular mortality in carriers of Duchenne and Becker muscular dystrophy.
DESIGN: Family pedigrees of individuals affected with these conditions, held by the four genetics centres in Scotland, were examined to identify a cohort of definite carriers. Electronic death registration data, held by the General Register Office for Scotland, were used to identify death certificates of carriers who had died, to obtain age at death and cause of death. Survival and mortality data were obtained for the general population for comparison. PATIENTS: 397 definite carriers in 202 pedigrees were identified from which 94 deaths were identified by record linkage to death certificates. MAIN OUTCOME MEASURES: Observed numbers surviving to certain ages and numbers dying of cardiac causes were compared with expected numbers calculated from general population data.
RESULTS: There were no significant differences between observed and expected numbers surviving to ages 40-90. The standardised mortality ratio for the 371 carriers alive in 1974 was 0.53 (95% confidence interval 0.32 to 0.82).
CONCLUSIONS: Whereas female carriers may have clinical features of cardiomyopathy, this study does not suggest that this is associated with reduced life expectancy or increased risk of cardiac death. Routine cardiac surveillance of obligate carriers is therefore probably unnecessary.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932095     DOI: 10.1136/hrt.2007.125948

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Exercise-induced left ventricular systolic dysfunction in women heterozygous for dystrophinopathy.

Authors:  Robert M Weiss; Richard E Kerber; Jane K Jones; Carrie M Stephan; Christina J Trout; Paul D Lindower; Kimberly S Staffey; Kevin P Campbell; Katherine D Mathews
Journal:  J Am Soc Echocardiogr       Date:  2010-06-19       Impact factor: 5.251

Review 2.  Progress in gene therapy of dystrophic heart disease.

Authors:  Y Lai; D Duan
Journal:  Gene Ther       Date:  2012-02-09       Impact factor: 5.250

3.  Early detection of cardiomyopathy in Duchenne muscular dystrophy, is there a role for MRI?

Authors:  Leo H B Baur
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-15       Impact factor: 2.357

Review 4.  Cardiomyopathy in becker muscular dystrophy: Overview.

Authors:  Rady Ho; My-Le Nguyen; Paul Mather
Journal:  World J Cardiol       Date:  2016-06-26

5.  Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

Authors:  Elizabeth M McNally; Jonathan R Kaltman; D Woodrow Benson; Charles E Canter; Linda H Cripe; Dongsheng Duan; Jonathan D Finder; William J Groh; Eric P Hoffman; Daniel P Judge; Naomi Kertesz; Kathi Kinnett; Roxanne Kirsch; Joseph M Metzger; Gail D Pearson; Jill A Rafael-Fortney; Subha V Raman; Christopher F Spurney; Shari L Targum; Kathryn R Wagner; Larry W Markham
Journal:  Circulation       Date:  2015-05-05       Impact factor: 29.690

Review 6.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

7.  Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.

Authors:  Takashi Iwase; Shoichiro Takao; Masashi Akaike; Katsuhito Adachi; Yuka Sumitomo-Ueda; Shusuke Yagi; Toshiyuki Niki; Kenya Kusunose; Noriko Tomita; Yoichiro Hirata; Koji Yamaguchi; Kunihiko Koshiba; Yoshio Taketani; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Ken-Ichi Aihara; Masafumi Harada; Hiromu Nishitani; Masataka Sata
Journal:  Heart Asia       Date:  2010-07-29

8.  Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging.

Authors:  Juliane Schelhorn; Anne Schoenecker; Ulrich Neudorf; Haemi Schemuth; Felix Nensa; Kai Nassenstein; Michael Forsting; Ulrike Schara; Thomas Schlosser
Journal:  Eur Radiol       Date:  2015-03-20       Impact factor: 5.315

9.  SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients.

Authors:  Eric N Jimenez-Vazquez; Michael Arad; Álvaro Macías; Maria L Vera-Pedrosa; Francisco Miguel Cruz; Lilian K Gutierrez; Ashley J Cuttita; André Monteiro da Rocha; Todd J Herron; Daniela Ponce-Balbuena; Guadalupe Guerrero-Serna; Ofer Binah; Daniel E Michele; José Jalife
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

10.  Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.

Authors:  John P Bourke; Teofila Bueser; Rosaline Quinlivan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.